Ir al contenido
· Rellenos dérmicos
SKU 11110

Revanesse Contour™+

En stock
Volumen
2 x 1,2 mL
Laboratorio
Prollenium Medical Technologies Inc.
Origen
Canadá
Indicación
Facial volume enhancement and contouring
Zonas de tratamiento
El precio profesional y su historial son solo para cuentas verificadas
allpara suministra a profesionales autorizados. Inicie sesión o solicite una cuenta B2B para ver los precios en tiempo real, los tramos por volumen y el historial de precios.
Etiquetas

Revanesse Contour+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, developed for medium to deep facial rhytides. Its cosmetic indication covers facial rhytides, volume restoration, lip augmentation, skin hydration and the contouring of depressions by injection into tissue, for intradermal use only. The gel contains 25 mg/mL of BDDE cross-linked hyaluronic acid with 3 mg/mL (0.3% w/w) lidocaine in phosphate-buffered saline and is intended for professional use. It is supplied as two pre-filled 1.2 mL syringes with up to two sterilised needles.

Principales ventajas de Revanesse Contour™+

  • Cross-linked hyaluronic acid 25 mg/mL with lidocaine 3 mg/mL for injection comfort
  • Indicated for medium to deep facial rhytides
  • Covers volume restoration, lip augmentation, skin hydration and contouring of depressions
  • Also indicated for volume lost to lipoatrophy or lipodystrophy, including HIV-associated cases
  • Supplied as two pre-filled 1.2 mL syringes with up to two sterilised needles
  • CE marked 0653 for the syringe, with CE 0123 needles
Información clave
Marca REVANESSE
Fabricante Prollenium Medical Technologies Inc.
País de origen Canada
Certificación CE marked 0653 for the syringe. The needles supplied are CE marked 0123.
Composición Cross-linked hyaluronic acid 25 mg/mL; lidocaine 3 mg/mL (0.3% w/w); in phosphate-buffered saline. Cross-linked with butanediol diglycidyl ether (BDDE).
Volumen / Tamaño 1.2 ml
Envase 2 pre-filled syringes x 1.2 mL, with up to two sterilised 27G needles
Tamaño de la aguja 27G, up to two supplied
Tipo de uso For professional use - injectable dermal filler with lidocaine, injected only by or under the direct supervision of qualified physicians trained in the technique for filling facial wrinkles
Profundidad de inyección Middle part of the dermis layer. Must not be injected into blood vessels, or into the eye contours (the eye circle or eyelids).
Protocolo / Duración Implantation life averages 6 to 12 months, depending on the depth and location of injection

Indicaciones y uso profesional

Indicaciones principales

  • Medium to deep facial rhytides
  • Restoration of volume lost from lipoatrophy or lipodystrophy
  • Correction of contour deficiencies and anatomic deformities of the facial soft tissue, of pathologic origin or after trauma
  • Volume restoration
  • Lip augmentation
  • Skin hydration
  • Contouring of depressions

Uso profesional

For professional use. Revanesse Contour+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. The area must be thoroughly disinfected and injection performed under sterile conditions. Bring the product to room temperature for 30 minutes before injection, prime the syringe until a small drop appears at the needle tip, then inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, must never be used for breast enlargement or implantation into bone, tendon, ligament or muscle, and must not contact quaternary ammonium salts such as benzalkonium chloride.

Zonas de tratamiento

  • Facial soft tissue
  • Lips

Perfil del paciente

Intended for patients desiring correction of contour deficiencies and deformities in facial soft tissue, including HIV-associated lipoatrophy and lipodystrophy. It is contraindicated in hypersensitivity to any amide-type local anaesthetic, not only lidocaine, and in all degrees of atrioventricular block, sinus node dysfunction, severe decline in myocardial contractility, porphyria and supraventricular tachycardias. It must not be used in pregnancy or lactation, in anyone under 18, in patients who develop hypertrophic scarring, in patients with acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, or unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. Safety in patients over 65 has not been established.

Cómo funciona Revanesse Contour™+ ​

Contour+ is a space-occupying tissue reconstructive material: the cross-linked hyaluronic acid gel occupies volume in the facial soft tissue where it is placed, correcting contour deficiencies rather than acting on the tissue biologically. Its medical indication is the restoration of volume lost from lipoatrophy or lipodystrophy and the correction of contour deficiencies and anatomic deformities, whether of pathologic origin or following trauma. The lidocaine at 0.3% is present for injection comfort, which is also why hypersensitivity to amide-type anaesthetics is an outright contraindication rather than a caution.

Por qué comprar en Allpara

Allpara ofrece productos REVANESSE originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.

Preguntas frecuentes

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke. Any patient showing changes in vision, signs of stroke or unusual pain during or shortly after the procedure needs prompt medical attention.

Is there a limit on how much can be injected in a year?

Yes. Based on a toxicological risk assessment for lidocaine, patients should be limited to 20 mL per 60 kg of body mass per annum. The safety of injecting greater amounts has not been established.

/ Especificaciones

La ficha técnica

Categoría
Rellenos dérmicos
Marca
REVANESSE
Laboratorio
Prollenium Medical Technologies Inc.
SKU
11110
Formato
2 x 1,2 mL
Origen
Canadá
Indicación
Facial volume enhancement and contouring
Uso
Professional dermal filler with lidocaine
Zonas de tratamiento
/ Detalles del producto

El expediente completo

Revanesse Contour+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, developed for medium to deep facial rhytides. Its cosmetic indication covers facial rhytides, volume restoration, lip augmentation, skin hydration and the contouring of depressions by injection into tissue, for intradermal use only. The gel contains 25 mg/mL of BDDE cross-linked hyaluronic acid with 3 mg/mL (0.3% w/w) lidocaine in phosphate-buffered saline and is intended for professional use. It is supplied as two pre-filled 1.2 mL syringes with up to two sterilised needles.

Prollenium Medical Technologies Inc., país de origen Canadá.

Enviado a toda la UE desde nuestro almacén en la UE, con seguimiento y seguro, y envío en 24-72h. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote.

Conservar según las especificaciones del fabricante, protegido de la luz directa. La cadena de frío solo se utiliza cuando el producto lo requiere.

Condiciones de pago a 30 / 60 / 90 días* disponibles para cuentas verificadas previa aprobación de crédito. Se admite la facturación en EUR, CHF y GBP.

Las condiciones son orientativas y se confirman tras la revisión de la cuenta.

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke. Any patient showing changes in vision, signs of stroke or unusual pain during or shortly after the procedure needs prompt medical attention.

Is there a limit on how much can be injected in a year?

Yes. Based on a toxicological risk assessment for lidocaine, patients should be limited to 20 mL per 60 kg of body mass per annum. The safety of injecting greater amounts has not been established.

/ Respuestas rápidas

Todo lo que un comprador pregunta primero

What should a practitioner do if the skin blanches during injection?
Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke. Any patient showing changes in vision, signs of stroke or unusual pain during or shortly after the procedure needs prompt medical attention.
Is there a limit on how much can be injected in a year?
Yes. Based on a toxicological risk assessment for lidocaine, patients should be limited to 20 mL per 60 kg of body mass per annum. The safety of injecting greater amounts has not been established.
/ FAQ

Preguntas frecuentes

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke. Any patient showing changes in vision, signs of stroke or unusual pain during or shortly after the procedure needs prompt medical attention.
Yes. Based on a toxicological risk assessment for lidocaine, patients should be limited to 20 mL per 60 kg of body mass per annum. The safety of injecting greater amounts has not been established.

Más productos de Prollenium Medical Technologies

Ver laboratorio

Alternativas para la clínica

Todos los productos

Revanesse Contour™+

En stock
Precios solo para cuentas verificadas
Inicie sesión o solicite una cuenta B2B para ver su precio.
Solicitar cuenta B2B

Revanesse Contour+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, developed for medium to deep facial rhytides. Its cosmetic indication covers facial rhytides, volume restoration, lip augmentation, skin hydration and the contouring of depressions by injection into tissue, for intradermal use only. The gel contains 25 mg/mL of BDDE cross-linked hyaluronic acid with 3 mg/mL (0.3% w/w) lidocaine in phosphate-buffered saline and is intended for professional use. It is supplied as two pre-filled 1.2 mL syringes with up to two sterilised needles.

Principales ventajas de Revanesse Contour™+

  • Cross-linked hyaluronic acid 25 mg/mL with lidocaine 3 mg/mL for injection comfort
  • Indicated for medium to deep facial rhytides
  • Covers volume restoration, lip augmentation, skin hydration and contouring of depressions
  • Also indicated for volume lost to lipoatrophy or lipodystrophy, including HIV-associated cases
  • Supplied as two pre-filled 1.2 mL syringes with up to two sterilised needles
  • CE marked 0653 for the syringe, with CE 0123 needles
Información clave
Marca REVANESSE
Fabricante Prollenium Medical Technologies Inc.
País de origen Canada
Certificación CE marked 0653 for the syringe. The needles supplied are CE marked 0123.
Composición Cross-linked hyaluronic acid 25 mg/mL; lidocaine 3 mg/mL (0.3% w/w); in phosphate-buffered saline. Cross-linked with butanediol diglycidyl ether (BDDE).
Volumen / Tamaño 1.2 ml
Envase 2 pre-filled syringes x 1.2 mL, with up to two sterilised 27G needles
Tamaño de la aguja 27G, up to two supplied
Tipo de uso For professional use - injectable dermal filler with lidocaine, injected only by or under the direct supervision of qualified physicians trained in the technique for filling facial wrinkles
Profundidad de inyección Middle part of the dermis layer. Must not be injected into blood vessels, or into the eye contours (the eye circle or eyelids).
Protocolo / Duración Implantation life averages 6 to 12 months, depending on the depth and location of injection

Indicaciones y uso profesional

Indicaciones principales

  • Medium to deep facial rhytides
  • Restoration of volume lost from lipoatrophy or lipodystrophy
  • Correction of contour deficiencies and anatomic deformities of the facial soft tissue, of pathologic origin or after trauma
  • Volume restoration
  • Lip augmentation
  • Skin hydration
  • Contouring of depressions

Uso profesional

For professional use. Revanesse Contour+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. The area must be thoroughly disinfected and injection performed under sterile conditions. Bring the product to room temperature for 30 minutes before injection, prime the syringe until a small drop appears at the needle tip, then inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, must never be used for breast enlargement or implantation into bone, tendon, ligament or muscle, and must not contact quaternary ammonium salts such as benzalkonium chloride.

Zonas de tratamiento

  • Facial soft tissue
  • Lips

Perfil del paciente

Intended for patients desiring correction of contour deficiencies and deformities in facial soft tissue, including HIV-associated lipoatrophy and lipodystrophy. It is contraindicated in hypersensitivity to any amide-type local anaesthetic, not only lidocaine, and in all degrees of atrioventricular block, sinus node dysfunction, severe decline in myocardial contractility, porphyria and supraventricular tachycardias. It must not be used in pregnancy or lactation, in anyone under 18, in patients who develop hypertrophic scarring, in patients with acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, or unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. Safety in patients over 65 has not been established.

Cómo funciona Revanesse Contour™+ ​

Contour+ is a space-occupying tissue reconstructive material: the cross-linked hyaluronic acid gel occupies volume in the facial soft tissue where it is placed, correcting contour deficiencies rather than acting on the tissue biologically. Its medical indication is the restoration of volume lost from lipoatrophy or lipodystrophy and the correction of contour deficiencies and anatomic deformities, whether of pathologic origin or following trauma. The lidocaine at 0.3% is present for injection comfort, which is also why hypersensitivity to amide-type anaesthetics is an outright contraindication rather than a caution.

Por qué comprar en Allpara

Allpara ofrece productos REVANESSE originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.

Preguntas frecuentes

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke. Any patient showing changes in vision, signs of stroke or unusual pain during or shortly after the procedure needs prompt medical attention.

Is there a limit on how much can be injected in a year?

Yes. Based on a toxicological risk assessment for lidocaine, patients should be limited to 20 mL per 60 kg of body mass per annum. The safety of injecting greater amounts has not been established.

Más productos de Prollenium Medical Technologies

Ver el laboratorio →

Revanesse Contour+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, developed for medium to deep facial rhytides. Its cosmetic indication covers facial rhytides, volume restoration, lip augmentation, skin hydration and the contouring of depressions by injection into tissue, for intradermal use only. The gel contains 25 mg/mL of BDDE cross-linked hyaluronic acid with 3 mg/mL (0.3% w/w) lidocaine in phosphate-buffered saline and is intended for professional use. It is supplied as two pre-filled 1.2 mL syringes with up to two sterilised needles.

Prollenium Medical Technologies Inc., país de origen Canadá.

Enviado a toda la UE desde nuestro almacén en la UE, envío en 24-72h, con seguimiento y seguro. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote. Conservar según las especificaciones del fabricante.

Pago a 30 / 60 / 90 días* para cuentas verificadas previa aprobación de crédito. Facturación en EUR, CHF y GBP.

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke. Any patient showing changes in vision, signs of stroke or unusual pain during or shortly after the procedure needs prompt medical attention.

Is there a limit on how much can be injected in a year?

Yes. Based on a toxicological risk assessment for lidocaine, patients should be limited to 20 mL per 60 kg of body mass per annum. The safety of injecting greater amounts has not been established.

* Producto de uso profesional. El envase puede variar según el lote o el mercado. Consulte las instrucciones de uso suministradas para las indicaciones completas y las contraindicaciones.